News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,026 Results
Type
Article (58)
Press Release (6968)
Section
Business (2605)
Career Advice (5)
Deals (383)
Drug Development (1318)
FDA (227)
Job Trends (412)
News (4256)
Policy (225)
Tag
Academia (8)
Allergies (6)
Alliances (90)
ALS (5)
Alzheimer's disease (55)
Antibody-drug conjugate (ADC) (9)
Approvals (273)
Artificial intelligence (5)
Autoimmune disease (3)
Best Places to Work (463)
Biosimilars (2)
Bladder cancer (12)
Breast cancer (32)
Cancer (223)
Cardiovascular disease (21)
Career advice (4)
CAR-T (3)
Cell therapy (10)
Cervical cancer (4)
Clinical research (1452)
Collaboration (12)
Compensation (5)
COVID-19 (11)
CRISPR (4)
C-suite (3)
Data (328)
Depression (3)
Diabetes (10)
Diagnostics (71)
Drug discovery (3)
Drug pricing (1)
Duchenne muscular dystrophy (3)
Earnings (2956)
Events (741)
Executive appointments (1)
FDA (380)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (10)
Gene editing (4)
Generative AI (1)
Gene therapy (14)
GLP-1 (14)
Government (25)
Guidances (55)
Healthcare (167)
HIV (3)
IgA nephropathy (5)
Immunology and inflammation (2)
Indications (4)
Infectious disease (19)
Inflammatory bowel disease (4)
Influenza (2)
Intellectual property (2)
IPO (326)
IRA (1)
Job creations (6)
Job search strategy (4)
Kidney cancer (2)
Layoffs (3)
Legal (11)
Liver cancer (1)
Lung cancer (54)
Lymphoma (24)
Manufacturing (4)
MASH (8)
Medical device (206)
Medtech (206)
Mergers & acquisitions (75)
Metabolic disorders (20)
Multiple sclerosis (9)
NASH (2)
Neurodegenerative disease (5)
Neuroscience (96)
NextGen: Class of 2026 (17)
Non-profit (20)
Obesity (3)
Opinion (1)
Ovarian cancer (8)
Pain (2)
Pancreatic cancer (3)
Parkinson's disease (13)
Partnered (1)
Patents (2)
Patient recruitment (2)
Peanut (5)
People (37)
Phase I (219)
Phase II (436)
Phase III (848)
Pipeline (273)
Policy (1)
Postmarket research (86)
Preclinical (33)
Prostate cancer (6)
Radiopharmaceuticals (7)
Rare diseases (16)
Real estate (2)
Regulatory (310)
Reports (2)
Research institute (10)
Resumes & cover letters (2)
Rett syndrome (2)
RSV (4)
Schizophrenia (6)
Series B (2)
Sickle cell disease (2)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (4)
Vaccines (14)
Weight loss (1)
Women's health (2)
Date
Last 7 days (7)
Last 30 days (35)
Last 365 days (900)
2026 (35)
2025 (914)
2024 (777)
2023 (760)
2022 (807)
2021 (873)
2020 (610)
2019 (414)
2018 (359)
2017 (269)
2016 (133)
2015 (188)
2014 (114)
2013 (69)
2012 (93)
2011 (99)
2010 (92)
Location
Africa (2)
Arizona (8)
Asia (533)
Australia (27)
California (275)
Canada (50)
China (31)
Colorado (4)
Connecticut (12)
Delaware (38)
Europe (1273)
Florida (36)
Georgia (8)
Illinois (22)
India (2)
Indiana (25)
Iowa (1)
Japan (34)
Kansas (6)
Maryland (33)
Massachusetts (177)
Michigan (7)
Minnesota (13)
Missouri (3)
Nevada (2)
New Jersey (175)
New York (66)
North Carolina (26)
Northern California (167)
Ohio (8)
Pennsylvania (59)
South America (7)
Southern California (88)
Tennessee (2)
Texas (36)
United States (1062)
Utah (9)
Virginia (4)
Washington State (21)
Wisconsin (2)
7,026 Results for "%E2%80%9D".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Stryker reports 2025 operating results and 2026 outlook
January 30, 2026
·
25 min read
Press Releases
Definium Therapeutics Common Shares to Trade under New Nasdaq Ticker Symbol “DFTX” Effective January 15, 2026
January 13, 2026
·
3 min read
Press Releases
Companion Spine Announces FDA Premarket Approval (“PMA”) of the DIAM™ Spinal Stabilization System for the Treatment of Degenerative Disc Disease (“DDD”)
December 15, 2025
·
10 min read
Press Releases
Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline
January 28, 2026
·
15 min read
Press Releases
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
December 10, 2025
·
3 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
January 29, 2026
·
23 min read
Press Releases
Almirall Announces “LumiNE”, a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema
January 16, 2026
·
7 min read
Press Releases
ImmunityBio Founder Dr. Patrick Soon-Shiong Recognized as One of “100 Most Influential People in Oncology in 2025”
December 29, 2025
·
3 min read
Press Releases
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
December 4, 2025
·
4 min read
Press Releases
CrossBridge Bio Wins “Best Drug Developer” at 2025 World ADC Awards
November 10, 2025
·
2 min read
1 of 703
Next
